Our Products and Technology
Particle-analysis technology that yields valuable insight
The capacity to characterize and quantify subvisible and visible particles in parenteral formulations and suspensions is critical for the pharmaceutical industry. ProteinSimple designed Micro-Flow Imaging specifically to meet the needs of pharmaceutical scientists at every stage of the drug-development and manufacturing process.
- MFI yields consistent, precise and repeatable results that help our clients improve their formulations. MFI is scalable and robust, and can be validated for use in cGMP production environments.
- MFI provides powerful, novel and unique insight into particle characterization and quantification with just a single test. Our clients use MFI to measure protein aggregates and particulates, air bubbles, silicone oil droplets and contaminants in the sub-visible and visible ranges.
- MFI helps users detect and diagnose problems sooner than traditional technology. MFI has been proven to identify trend changes in particle populations that traditional technologies—such as light obscuration (LO) and size exclusion chromatography (SEC)—have been demonstrated to miss.
- MFI is easy to operate and provides automated sample introduction for unattended operation.
The pharmaceutical industry relies on MFI
We are proud of MFI because of its impressive capabilities and because of the way in which it has been embraced by the pharmaceutical industry. The world’s ten largest pharmaceutical companies—and 18 of the top 20—use MFI. The technology has been qualified and validated within the industry. And it is regularly referenced by many international regulatory agencies.
Learn more about how MFI yields valuable, actionable insight. Read about its features and benefits, as well as the exceptional products and services that support this class-leading technology.
